Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001562230-25-000046·Capital International Investors
Schedule 13G ownership disclosure
Sarepta Therapeutics Inc
Common Stock · CUSIP: 803607100
Event date: 2024-12-31
- Filing-level shares
- 8,896,223.00
- Percent of class
- 9.3%
- Capital International Investors
Shares: 8,896,223.00 · Class: 9.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001562230-25-000046
- Form type
- SCHEDULE 13G/A
- Filer
- Capital International Investors
- CIK
- CIK 1562230
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership